Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma

Clinical trial NCT02217956 · COMPLETED

Trial details

NCT number: NCT02217956
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Adenocarcinoma Fallopian Tube Adenocarcinoma Primary Peritoneal Carcinoma

Start date: 2011-06-01
Primary completion: 2015-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.